Leukemia: Lessons from the Japanese experience

Stem Cells

Volumn 15, Issue SUPPL. 2, 1997, Pages 135-139

  Finch, Stuart C ^a  

^a Department of Anesthesiology   (United States)

Author keywords

Atomic bomb; Japan; Leukemia; Life Span Study; Radiation

Indexed keywords

ATOMIC BOMB SURVIVOR; CANCER INCIDENCE; CONFERENCE PAPER; DISEASE COURSE; DOSE RESPONSE; HUMAN; LATENT PERIOD; LEUKEMIA; ONSET AGE; RADIATION DOSE; RADIATION INJURY;

EID: 0030724503     PISSN: 10665099     EISSN: None     Source Type: Journal    
DOI: 10.1002/stem.5530150720     Document Type: Conference Paper

References (18)

1. UNSCEAR, Sources, Effects, and Risks of Ionizing Radiation, Report to the General Assembly, with Annexes, United Nations, New York, 1994:93,112.
2. Shimizu Y, Kato H, Schull WJ. Studies of the Mortality of A-Bomb Survivors. 9. Mortality, 1950-1985: Part 2. Cancer Mortality Based on the Recently Revised Doses (DS86). Radiat Res 1990;121:120-141.
3. Preston DL, Kusumi S, Tomonaga M et al. Cancer incidence in atomic bomb survivors. Part iii: leukemia, lymphoma and multiple myeloma, 1950-1987. Radiat Res 1994;137:S68-S97.
4. Finch SC, Hrubec Z, Nefzger MD et al. Detection of Leukemia and Related Disorders, Hiroshima and Nagasaki. Research Plan. TR 5-65, Atomic Bomb Casualty Commission, Hiroshima, 1965.
5. Roesch WC, ed., Final Report of US-Japan Joint Reassessment of Atomic Bomb Radiation Dosimetry in Hiroshima and Nagasaki. Radiation Effects Research Foundation, Hiroshima, 1987.
6. Brenner DJ. Direct biological evidence for a significant neutron dose to the survivors of the Hiroshima atomic bomb. Abstract of the Forty-fourth Annual Meeting of the Radiation Research Society, 1996:116.
7. Pierce DA, Preston DL. Risks from low doses of radiation. Science 1995;272:631-632.
8. Matsuo T, Tomonaga M, Bennett JM et al. Reclassification of leukemia among A-bomb survivors using French-American-British (FAB) classification for acute leukemia. Jpn J Clin Oncol 1988;18:91-96.
9. Tomanaga M, Matsuo T, Carter RL et al. Differential Effects of Atomic Bomb Irradiation in Inducing Major Leukemia Types (AML, ALL and CML): Analysis of Open-City Cases Including Life Span Study Cohort Based upon Up-dated Diagnostic Systems and the New Dosimetry System (DS86). TR 9-91, Radiation Effects Research Foundation, Hiroshima, 1991.
10. Ron E, Preston DL, Mabuchi K et al. Cancer Incidence in Atomic Bomb Survivors. Part IV: Comparison of Cancer Incidence and Mortality. TR 11-92, Radiation Effects Research Foundation, Hiroshima, 1993.
11. Folley IH, Borges W, Yamawaki T. Incidence of leukemia in survivors of the atomic bomb in Hiroshima and Nagasaki. Jpn Am J Med 1952;13:311-321.
12. Finch SC, Hoshino T, Itoga T et al. Chronic lymphocytic leukemia in Hiroshima and Nagasaki. Jpn Blood 1969;3:79-86.
13. National Research Council, Committee on the Biological Effects of Ionizing Radiation, Health Effects of Exposure to Low Levels of Ionizing Radiation (BEIR V). Washington DC: National Academy Press, 1990.
14. Yoshimoto Y, Kato H, Schull WJ. A review of forty-five years study of Hiroshima and Nagasaki atomic bomb survivors. Cancer risk among in utero-exposed survivors. J Radiat Res 1991;32:S231-S238.
15. Yoshimoto Y. Cancer risk among children of atomic bomb survivors: a review of RERF epidemiologic studies. JAMA 1990;264:596-600.
16. 1) of atomic bomb survivors. J Radiat Res 1991;32:S294-S300.
17. Neriishi K, Stram DO, Vaeth M et al. The observed relationship between the occurrence of acute radiation effects and leukemia mortality among a-bomb survivors. Radiat Res 1991;125:206-213.
18. Pierce DA, Shimizu Y, Preston DL et al. Studies of the mortality of atomic bomb survivors. Report 12, Part 1. Cancer 1950-1990. Radiat Res 1996;146:1-27.